Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.
about
The emerging role of miR-506 in cancerMicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentThe immunogenetics of primary biliary cirrhosis: A comprehensive reviewMicroRNAs and benign biliary tract diseasesHDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesisWhy Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications?MicroRNAs in liver diseaseMicroRNAs in Cholangiopathies.HDAC6 inhibition restores ciliary expression and decreases tumor growthCholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitisRole of cholangiocytes in primary biliary cirrhosis.Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitisThe SLC4 family of bicarbonate (HCO₃⁻) transporters.Serum microRNAs as potential biomarkers of primary biliary cirrhosisAbsence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506.Identification of microRNAs in the coral Stylophora pistillataRole of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosisInhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseasesMiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanismsMicroRNA 224 Regulates Ion Transporter Expression in Ameloblasts To Coordinate Enamel Mineralization.The Cholangiopathies.MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis.microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1)MicroRNAs in biliary diseases.CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitisSoluble Adenylyl Cyclase Regulates Bile Salt-Induced Apoptosis in Human Cholangiocytes.Role of AE2 for pHi regulation in biliary epithelial cells.Recent advances in the morphological and functional heterogeneity of the biliary epitheliumMicroRNA control in the development of systemic autoimmunity.Effect of drug transporter pharmacogenetics on cholestasis.The physiological roles of secretin and its receptor.Primary biliary cirrhosis: safety and benefits of established and emerging therapies.Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.Management of cholestatic disease in 2017.miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.Saturated free fatty acids induce cholangiocyte lipoapoptosis.miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.
P2860
Q26740283-A8A6E327-67EF-4153-914C-F752DD7BCF81Q26783579-3BF31D39-3D6D-4CEE-ADB0-DEBC96DFC03CQ26801377-505CBD90-519E-413E-B1DC-3E78B8979381Q26865762-870EF936-2C2B-42C7-BCAA-E3D32084976FQ28572123-1F6608AB-082D-455F-B708-C4909D4DE5C1Q33840969-12C642CA-0C60-48D9-B2D2-91D50480517EQ33880442-01F0C2AB-F46B-45AF-8966-17FC4E1C2EFCQ33991899-DB2504CD-92DE-42F0-AAE4-27992BC7CCF5Q34035361-50A0A572-5BC1-4BD0-9B4E-FB92C03B1443Q34206508-92ECBAA4-0670-497A-A4B7-420B0E2F1773Q34276575-3DF95656-2C20-4C6C-A333-6052309E5DB9Q34287861-17123595-D797-43CF-B9DF-525CFC02F1ECQ34333694-7E48D8A8-5723-4932-AAB6-26E6D6F91010Q34408701-3A3AED90-5C80-44EF-AE27-06174EE4D231Q34479345-3B7F042B-DD74-4FBB-A36A-ABF74D025D93Q34494216-1F60FDD7-03C5-437D-8F46-F99E911394EDQ34801354-C573DEEE-65FD-427B-B249-2DCA6371BE42Q35128292-061E41C9-A478-4CD5-A1E7-8E734D7F4CF4Q35159893-26ADFD6A-641F-4DDE-A134-815E5B89E4CBQ35185224-7227806F-0D21-4A30-AF45-78EC9BB0BD5BQ35202716-B5D8B1DB-1B59-4E86-8556-D1DE69B5995BQ35236464-3A0C4DAB-9753-4490-AEF1-35539EC5AE4AQ35868382-6F6847B1-6984-4EDE-9422-3C7991EAF6D0Q35942610-8E1BC78E-3868-4129-A880-75CFF1572FABQ36144748-8E607F47-6954-4057-A6AA-6A05127958A0Q36250621-4FEAD4D0-C6B7-4AEA-8467-822D6FACF9C2Q36410357-3B695045-FC0D-4C5B-8601-E56567480705Q36557102-F6FF3C46-E832-47BB-B79E-C141BA7B59A6Q37418108-A9B23A18-0756-4372-8022-7ADE5A554A51Q37488881-D5C3DD32-10B6-478C-AD85-4D956306F249Q37662251-55C26C32-2711-49FE-934E-6BC6CE944A4AQ38078996-7ABBB748-450B-4445-A0B6-A3AAA15CFD78Q38254730-8E99A58F-9E5E-4A6B-9CF3-3DF2A28E42EFQ38261684-01265580-2B18-4509-AF9D-EEE4B17C8E37Q38554677-3B64D8D4-CC71-4924-8C35-5BB7CCA69B16Q38565478-6ABE1221-49D4-4EE8-9212-5C1356E91252Q38774857-19C4C7F9-23C2-428F-9EB6-A665484EDE97Q38848862-A0D8731C-2337-4E68-B045-C739D80C1174Q39002205-4F179572-D020-4302-8B89-6CE51E1EEF7CQ39017343-3C31793F-67C5-4BE6-860C-3E2D798BBD68
P2860
Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Up-regulation of microRNA 506 ...... ith primary biliary cirrhosis.
@ast
Up-regulation of microRNA 506 ...... ith primary biliary cirrhosis.
@en
type
label
Up-regulation of microRNA 506 ...... ith primary biliary cirrhosis.
@ast
Up-regulation of microRNA 506 ...... ith primary biliary cirrhosis.
@en
prefLabel
Up-regulation of microRNA 506 ...... ith primary biliary cirrhosis.
@ast
Up-regulation of microRNA 506 ...... ith primary biliary cirrhosis.
@en
P2093
P2860
P50
P356
P1433
P1476
Up-regulation of microRNA 506 ...... with primary biliary cirrhosis
@en
P2093
Aura D Urribarri
Elena Sáez
Juan F Medina
Miriam Uriz
Nicholas F LaRusso
Pamela S Tietz Bogert
Patrick Splinter
Sarai Sarvide
P2860
P304
P356
10.1002/HEP.25691
P407
P577
2012-07-10T00:00:00Z